Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,778.00
Bid: 1,774.00
Ask: 1,774.50
Change: -10.50 (-0.59%)
Spread: 0.50 (0.028%)
Open: 1,796.00
High: 1,808.50
Low: 1,772.50
Prev. Close: 1,788.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Panmure Upgrades Shire To Buy From Hold

Thu, 16th Oct 2014 08:36

LONDON (Alliance News) - The following UK shares received analyst recommendations Thursday morning:
----------
FTSE 100
----------
BERENBERG CUTS ROLLS-ROYCE PRICE TARGET TO 1160 (1216) PENCE - 'BUY'
----------
UBS RAISES ANTOFAGASTA TO 'NEUTRAL' ('SELL') - TARGET 710 PENCE
----------
UBS CUTS ANGLO AMERICAN PRICE TARGET TO 1450 (1700) PENCE - 'NEUTRAL'
----------
UBS CUTS BHP BILLITON PRICE TARGET TO 2100 (2300) PENCE - 'BUY'
----------
UBS CUTS RIO TINTO PRICE TARGET TO 3500 (3900) PENCE - 'BUY'
----------
GOLDMAN RAISES RIO TINTO PRICE TARGET TO 2600 (2550) PENCE - 'CONVICTION SELL LIST'
----------
UBS CUTS FRESNILLO PRICE TARGET TO 1000 (1050) PENCE - 'BUY'
----------
BARCLAYS RAISES ASTRAZENECA PRICE TARGET TO 4150 (4100) PENCE - 'EQUAL WEIGHT'
----------
TRADERS: MERRILL LYNCH ADDS ASTRAZENECA TO 'EUROPE 1 LIST'
----------
BARCLAYS CUTS GLAXOSMITHKLINE PRICE TARGET TO 1485 (1500) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES SHIRE PRICE TARGET TO 4100 (3900) PENCE - 'OVERWEIGHT'
----------
PANMURE RAISES SHIRE TO 'BUY' ('HOLD') - TARGET 4200 (5300) PENCE
----------
GOLDMAN CUTS BABCOCK INTERNATIONAL PRICE TARGET TO 1380 (1405) PENCE - 'BUY'
----------
CREDIT SUISSE CUTS ARM PRICE TARGET TO 1000 (1100) PENCE - 'OUTPERFORM'
----------
HSBC CUTS WPP PRICE TARGET TO 1540 (1600) PENCE - 'OVERWEIGHT'
----------
TRADERS: NUMIS RAISES WHITBREAD TO 'ADD' ('HOLD')
----------
Numis Cuts Diageo Price Target To 1,800p From 1,900p, Reiterates Hold
----------
FTSE 250
----------
UBS RAISES BELLWAY PRICE TARGET TO 1910 (1870) PENCE - 'BUY'
----------
UBS REMOVES FERREXPO FROM 'LEAST PREFERRED LIST' - 'SELL'
----------
UBS CUTS FERREXPO PRICE TARGET TO 80 (100) PENCE - 'SELL'
----------
UBS CUTS HOCHSCHILD MINING PRICE TARGET TO 135 (185) PENCE - 'NEUTRAL'
----------
UBS CUTS KAZAKHMYS PRICE TARGET TO 340 (370) PENCE - 'BUY'
----------
UBS CUTS LONMIN PRICE TARGET TO 190 (250) PENCE - 'NEUTRAL'
----------
UBS CUTS POLYMETAL PRICE TARGET TO 500 (550) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS BARRATT DEVELOPMENTS PRICE TARGET TO 499 (530) PENCE - 'BUY'
----------
GOLDMAN RAISES BERKELEY GROUP PRICE TARGET TO 2871 (2870) PENCE - 'NEUTRAL'
----------
Numis Upgrades Bank Of Georgia To Buy From Hold, Price Target 2,708 pence
----------
MAIN MARKET AND AIM
----------
GOLDMAN CUTS ASOS PRICE TARGET TO 3000 (4300) PENCE - 'BUY'
----------
GOLDMAN CUTS SHANKS GROUP PRICE TARGET TO 109 (128) PENCE - 'BUY'
----------
Liberum Raises Game Digital Price Target To 265p From 350p, Buy
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
23 May 2024 19:21

Zantac not a cause of woman’s cancer, jury says in first trial over drug

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations.

Read more
22 May 2024 22:59

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 22 (Reuters) -

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more
17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake

*

Read more
17 May 2024 15:52

London close: Stocks recoup some earlier losses

(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.

Read more
17 May 2024 11:52

LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady

(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.

Read more
17 May 2024 09:03

TOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billion

(Alliance News) - GSK PLC on Friday said it has sold its remaining shares in Haleon PLC, marking a total exit from its consumer healthcare spin-off.

Read more
17 May 2024 08:56

LONDON MARKET OPEN: FTSE 100 lacklustre as Wall Street rally ends

(Alliance News) - Stock prices in London opened lower on Friday, after Thursday saw Wall Street's rally end in a record breaking session.

Read more
17 May 2024 08:39

GSK raises $1.5 bln from sale of remaining Haleon stake

May 17 (Reuters) - British drugmaker GSK has raised 1.25 billion pounds ($1.52 billion) from a sale of its remaining stake in consumer healthcare company Haleon to institutional investors.

Read more
17 May 2024 07:42

LONDON BRIEFING: Land Securities ups dividend; GSK sells Haleon stake

(Alliance News) - Stocks in London are called to open lower, as investors wait for an inflation reading from the eurozone later this morning.

Read more
17 May 2024 07:29

GSK raises £1.25bn from sale of remaining Haleon stake

(Sharecast News) - GSK said on Friday that it has sold its remaining 4.2% stake in consumer health business Haleon, which it spun off in July 2022.

Read more
16 May 2024 17:33

FTSE 100 ends lower on disappointing corporate updates, BT Group soars

BT Group up after CEO aims for more than double free cash flow

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.